Over the next month Canada will be experiencing a 'temporary' delay in Pfizer-BioNTech vaccine shipments due to the pharmaceutical giant's expansion plans at its European manufacturing facility, with the shortage resulting in an average of 50 per cent of coming doses delayed each week.